More recently, risk factors for the development of allergic asthma and respiratory disease in patients with AD background have been identified: they are represented by greater disease severity, early onset [15] and elevated specific IgE with early sensitization [16], despite the few studies conducted on clinical predictive value of IgE. This evidence concerns the gene IGHE and respiratory system disorder.